New approaches under study at UVA could revolutionize treatment for conditions from Alzheimer’s to epilepsy to brain tumors – and even help repair the devastating damage caused by stroke.
Jim Galloway and Timothy Wilson last week became the fourth and fifth UVA faculty members elected to the National Academy of Sciences for their pathbreaking research.
The University’s institute, dedicated to the environment, continues to work through the pandemic.
People who have recovered from COVID-19 have antibodies that may confer immunity. Sharing them may be helpful to those who are still battling the disease.
The FDA issued emergency-use authorization allowing the use of remdesivir, an antiviral drug tested at UVA Health.
The new fund will serve as a catalyst for vital research focused on COVID-19 testing, therapies, vaccines and even strategies to safely reopen society.
Remdesivir, an antiviral drug tested against COVID-19 at UVA Health and other sites, appeared to improve survival rates and speed recovery times.
Two of the School of Medicine’s leading researchers are teaming to take on something that neither may have attempted on their own: the riddle of spinal cord injuries.